Atossa Therapeutics
ATOS
#9994
Rank
A$59.74 M
Marketcap
A$6.94
Share price
-6.40%
Change (1 day)
540.20%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -A$46.92 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$36.68 Million, an increase over its 2023 earnings that were of -A$43.28 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$46.92 Million27.94%
2024 -A$36.68 Million-15.25%
2023 -A$43.28 Million11.62%
2022 -A$38.77 Million30.84%
2021 -A$29.64 Million15.58%
2020 -A$25.64 Million3.41%
2019 -A$24.8 Million51.16%
2018 -A$16.41 Million40.41%
2017 -A$11.69 Million27.54%
2016 -A$9.16 Million-47.49%
2015 -A$17.45 Million-17.25%
2014 -A$21.08 Million35.91%
2013 -A$15.51 Million112.3%
2012 -A$7.31 Million46.53%
2011 -A$4.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$48.24 B-111,272.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$1.89 B-4,467.13%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$1.91 B-4,512.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
A$59.93 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-A$0.16 Billion 261.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-A$11.28 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA